These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
60 related articles for article (PubMed ID: 8613961)
1. Uptake of [N-methyl-11C]propionyl-L-carnitine (PLC) in human myocardium. Cunningham VJ; Rosen SD; Boyd H; Osman S; Davenport RJ; Gunn RN; Pike VW; Camici PG J Pharmacol Exp Ther; 1996 Apr; 277(1):511-7. PubMed ID: 8613961 [TBL] [Abstract][Full Text] [Related]
2. Propionyl-L-carnitine: labelling in the N-methyl position with carbon-11 and pharmacokinetic studies in rats. Davenport RJ; Law MP; Pike VW; Osman S; Poole KG Nucl Med Biol; 1995 Aug; 22(6):699-709. PubMed ID: 8535330 [TBL] [Abstract][Full Text] [Related]
3. Disposition of L-carnitine and its short-chain esters, acetyl-L-carnitine and propionyl-L-carnitine, in the rat isolated perfused liver. Mancinelli A; Longo A; Nation RL; Evans AM Drug Metab Dispos; 2000 Dec; 28(12):1401-4. PubMed ID: 11095575 [No Abstract] [Full Text] [Related]
4. Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review. Ferrari R; Merli E; Cicchitelli G; Mele D; Fucili A; Ceconi C Ann N Y Acad Sci; 2004 Nov; 1033():79-91. PubMed ID: 15591005 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of propionyl-L-carnitine in humans: evidence for saturable tubular reabsorption. Pace S; Longo A; Toon S; Rolan P; Evans AM Br J Clin Pharmacol; 2000 Nov; 50(5):441-8. PubMed ID: 11069438 [TBL] [Abstract][Full Text] [Related]
6. Studies on the metabolism of the novel antitumor agent [N-methyl-11C]N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in rats and humans prior to phase I clinical trials. Osman S; Luthra SK; Brady F; Hume SP; Brown G; Harte RJ; Matthews JC; Denny WA; Baguley BC; Jones T; Price PM Cancer Res; 1997 Jun; 57(11):2172-80. PubMed ID: 9187117 [TBL] [Abstract][Full Text] [Related]
7. Homeostatic equilibrium of L-carnitine family before and after i.v. administration of propionyl-L-carnitine in humans, dogs and rats. Marzo A; Cardace G; Corbelleta C; Bassani E; Morabito E; Arrigoni Martelli E Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():357-63. PubMed ID: 1820908 [TBL] [Abstract][Full Text] [Related]
8. Automated chemoenzymatic synthesis of no-carrier-added [carbonyl-11C]propionyl L-carnitine for pharmacokinetic studies. Davenport RJ; Pike VW; Dowsett K; Turton DR; Poole K Appl Radiat Isot; 1997 Jul; 48(7):917-24. PubMed ID: 9376826 [TBL] [Abstract][Full Text] [Related]
9. Propionyl-L-carnitine improves hemodynamics and metabolic markers of cardiac perfusion during coronary surgery in diabetic patients. Lango R; Smoleński RT; Rogowski J; Siebert J; Wujtewicz M; Słomińska EM; Lysiak-Szydłowska W; Yacoub MH Cardiovasc Drugs Ther; 2005 Aug; 19(4):267-75. PubMed ID: 16187006 [TBL] [Abstract][Full Text] [Related]
10. Effect of L-propionyl carnitine on in-vitro membrane alteration of sickle-cell anaemia erythrocytes. Ronca F; Palmieri L; Malengo S; Bertelli A Int J Tissue React; 1994; 16(4):187-94. PubMed ID: 7797405 [TBL] [Abstract][Full Text] [Related]
11. L-propionyl carnitine reduces toxicity correlated to cyclosporine-induced intracellular ATP concentrations. Giovannini L; Migliori M; De Pietro S; Taccola D; Panichi V; Bertelli AA; Bertelli A Drugs Exp Clin Res; 1999; 25(4):173-7. PubMed ID: 10442274 [TBL] [Abstract][Full Text] [Related]
12. L-Propionyl carnitine, homocysteine and S-adenosylhomocysteine in hemodialysis. Perna AF; Acanfora F; Satta E; Lombardi C; Capasso R; Ingrosso D; De Santo NG J Nephrol; 2007; 20(1):63-5. PubMed ID: 17347975 [TBL] [Abstract][Full Text] [Related]
13. Rheological activity of propionyl L-carnitine. Pola P; Flore R; Tondi P; Nolfe G Drugs Exp Clin Res; 1991; 17(3):191-6. PubMed ID: 1914846 [TBL] [Abstract][Full Text] [Related]
14. Anaplerotic effect of propionyl carnitine in rat heart mitochondria. Tassani V; Cattapan F; Magnanimi L; Peschechera A Biochem Biophys Res Commun; 1994 Mar; 199(2):949-53. PubMed ID: 8135845 [TBL] [Abstract][Full Text] [Related]
15. The effect of propionyl L-carnitine on skeletal muscle metabolism in renal failure. Thompson CH; Irish AB; Kemp GJ; Taylor DJ; Radda GK Clin Nephrol; 1997 Jun; 47(6):372-8. PubMed ID: 9202867 [TBL] [Abstract][Full Text] [Related]
16. Effects of propionyl-L-carnitine topical irrigation in distal ulcerative colitis: a preliminary report. Gasbarrini G; Mingrone G; Giancaterini A; De Gaetano A; Scarfone A; Capristo E; Calvani M; Caso V; Greco AV Hepatogastroenterology; 2003; 50(53):1385-9. PubMed ID: 14571743 [TBL] [Abstract][Full Text] [Related]
17. Effects of propionyl-L-carnitine on peripheral arterial obliterative disease of the lower limbs: a double-blind clinical trial. Dal Lago A; De Martini D; Flore R; Gaetani E; Gasbarrini A; Gerardino L; Pola R; Santoliquido A; Serricchio M; Tondi P; Nolfe G Drugs Exp Clin Res; 1999; 25(1):29-36. PubMed ID: 10337502 [TBL] [Abstract][Full Text] [Related]
18. Uptake of L-carnitine and its short-chain ester propionyl-L-carnitine in the isolated perfused rat liver. Mancinelli A; Evans AM; Nation RL; Longo A J Pharmacol Exp Ther; 2005 Oct; 315(1):118-24. PubMed ID: 15951397 [TBL] [Abstract][Full Text] [Related]
19. Excretion and metabolism of propionyl-L-carnitine in the isolated perfused rat kidney. Evans AM; Mancinelli A; Longo A J Pharmacol Exp Ther; 1997 Jun; 281(3):1071-6. PubMed ID: 9190838 [TBL] [Abstract][Full Text] [Related]